REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 166 filers reported holding REGENXBIO INC in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,362,464 | -8.9% | 751,061 | +10.6% | 0.00% | 0.0% |
Q2 2023 | $13,573,130 | -6.2% | 678,996 | -11.2% | 0.00% | 0.0% |
Q1 2023 | $14,465,337 | +3.1% | 764,957 | +23.7% | 0.00% | 0.0% |
Q4 2022 | $14,028,419 | +841.5% | 618,537 | +997.3% | 0.00% | – |
Q3 2022 | $1,490,000 | +141.1% | 56,371 | +125.5% | 0.00% | – |
Q2 2022 | $618,000 | -89.9% | 25,000 | -86.5% | 0.00% | -100.0% |
Q1 2022 | $6,133,000 | -67.4% | 184,773 | -67.9% | 0.00% | -75.0% |
Q4 2021 | $18,803,000 | +80.7% | 575,017 | +131.7% | 0.00% | +100.0% |
Q3 2021 | $10,403,000 | +84.0% | 248,178 | +70.5% | 0.00% | +100.0% |
Q2 2021 | $5,654,000 | +26.2% | 145,565 | +10.8% | 0.00% | 0.0% |
Q1 2021 | $4,479,000 | -61.4% | 131,319 | -48.7% | 0.00% | -66.7% |
Q4 2020 | $11,612,000 | +264.2% | 255,978 | +120.9% | 0.00% | +200.0% |
Q3 2020 | $3,188,000 | +4.4% | 115,860 | +39.7% | 0.00% | 0.0% |
Q2 2020 | $3,055,000 | -18.5% | 82,945 | -28.3% | 0.00% | -66.7% |
Q1 2020 | $3,747,000 | -37.8% | 115,695 | -21.3% | 0.00% | 0.0% |
Q4 2019 | $6,020,000 | -30.8% | 146,971 | -39.9% | 0.00% | -25.0% |
Q3 2019 | $8,699,000 | +102.7% | 244,359 | +192.5% | 0.00% | +100.0% |
Q2 2019 | $4,291,000 | -84.2% | 83,550 | -82.4% | 0.00% | -85.7% |
Q1 2019 | $27,154,000 | +26.0% | 473,823 | -7.8% | 0.01% | +16.7% |
Q4 2018 | $21,553,000 | -48.9% | 513,759 | -8.0% | 0.01% | -36.8% |
Q3 2018 | $42,144,000 | +753.1% | 558,200 | +710.8% | 0.02% | +850.0% |
Q2 2018 | $4,940,000 | -79.1% | 68,849 | -91.3% | 0.00% | -84.6% |
Q1 2018 | $23,622,000 | -28.1% | 791,356 | -19.9% | 0.01% | -35.0% |
Q4 2017 | $32,843,000 | +63.6% | 987,752 | +62.2% | 0.02% | +33.3% |
Q3 2017 | $20,072,000 | +9.7% | 609,140 | -34.2% | 0.02% | 0.0% |
Q2 2017 | $18,292,000 | +69.3% | 926,176 | +65.4% | 0.02% | +50.0% |
Q1 2017 | $10,806,000 | +654.6% | 559,887 | +625.1% | 0.01% | +900.0% |
Q4 2016 | $1,432,000 | +915.6% | 77,220 | +668.1% | 0.00% | – |
Q3 2016 | $141,000 | -87.6% | 10,053 | -80.5% | 0.00% | -100.0% |
Q3 2015 | $1,139,000 | – | 51,686 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |